Cargando…
Cytogenetic profile of 1791 adult acute myeloid leukemia in India
BACKGROUND: Cytogenetic analysis continues to have an important role in the management of acute myeloid leukemia (AML) because it is essential for prognostication. It is also necessary to diagnose specific categories of AML and to determine the most effective form of treatment. Reports from South As...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504794/ https://www.ncbi.nlm.nih.gov/pubmed/37716945 http://dx.doi.org/10.1186/s13039-023-00653-1 |
_version_ | 1785106805528985600 |
---|---|
author | Srivastava, Vivi M. Nair, Sukesh Chandran Sappani, Marimuthu Manipadam, Marie-Therese Kulkarni, Uday P. Devasia, Anup J. Fouzia, N. A. Korula, Anu Lakshmi, Kavitha M. Abraham, Aby Srivastava, Alok |
author_facet | Srivastava, Vivi M. Nair, Sukesh Chandran Sappani, Marimuthu Manipadam, Marie-Therese Kulkarni, Uday P. Devasia, Anup J. Fouzia, N. A. Korula, Anu Lakshmi, Kavitha M. Abraham, Aby Srivastava, Alok |
author_sort | Srivastava, Vivi M. |
collection | PubMed |
description | BACKGROUND: Cytogenetic analysis continues to have an important role in the management of acute myeloid leukemia (AML) because it is essential for prognostication. It is also necessary to diagnose specific categories of AML and to determine the most effective form of treatment. Reports from South Asia are few because the availability of cytogenetic services is relatively limited. METHODS: We performed a retrospective analysis of the cytogenetic findings in adults with AML seen consecutively in a single centre in India. The results were categorised according to the 2022 World Health Organisation (WHO), International Consensus Classification (ICC) and European LeukemiaNet (ELN) classifications. RESULTS: There were 1791 patients aged 18–85 years (median age 42, 1086 males). Normal karyotypes were seen in 646 (36%) patients. The 1145 (64%) abnormal karyotypes comprised 585 (32.7%) with recurrent genetic abnormalities (RGA), 403 (22.5%) with myelodysplasia-related cytogenetic abnormalities (MRC), and 157 (8.8%) with other abnormalities. There were 567 (31.7%) patients with solitary abnormalities and 299 (16.7%) with two abnormalities. Among the 279 (15.6%) patients with ≥ 3 abnormalities, 200 (11.2%) had complex karyotypes (CK) as per the WHO/ICC and 184 (10.3%), as per the ELN definition. There were 158 (8.8%) monosomal karyotypes (MK). Patients with normal karyotypes had a higher median age (45 years) than those with abnormal karyotypes (40 years, p < 0.001), and those with ≥ 3 abnormalities (43 years), than those with fewer abnormalities (39 years, p = 0.005). Patients with CK (WHO/ICC) and monosomal karyotypes had a median age of 48 years. Those with RGA had a lower median age (35 years, p < 0.001) than MRC (46 years) or other abnormalities (44 years). The t(15;17) was the most common abnormality (16.7%),followed by trisomy 8 (11.6%), monosomy 7/del 7q (9.3%), t(8;21) (7.2%), monosomy 5/del 5q (6.7%) and monosomy 17/del 17p (5.2%). CONCLUSION: Our findings confirm the lower age profile of AML in India and show similarities and differences with respect to the frequencies of individual abnormalities compared to the literature. The frequencies of the t(15;17), trisomy 8 and the high-risk abnormalities monosomy 7 and monosomy 5/del 5q were higher, and that of the inv(16), lower than in most reports. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13039-023-00653-1. |
format | Online Article Text |
id | pubmed-10504794 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105047942023-09-17 Cytogenetic profile of 1791 adult acute myeloid leukemia in India Srivastava, Vivi M. Nair, Sukesh Chandran Sappani, Marimuthu Manipadam, Marie-Therese Kulkarni, Uday P. Devasia, Anup J. Fouzia, N. A. Korula, Anu Lakshmi, Kavitha M. Abraham, Aby Srivastava, Alok Mol Cytogenet Research BACKGROUND: Cytogenetic analysis continues to have an important role in the management of acute myeloid leukemia (AML) because it is essential for prognostication. It is also necessary to diagnose specific categories of AML and to determine the most effective form of treatment. Reports from South Asia are few because the availability of cytogenetic services is relatively limited. METHODS: We performed a retrospective analysis of the cytogenetic findings in adults with AML seen consecutively in a single centre in India. The results were categorised according to the 2022 World Health Organisation (WHO), International Consensus Classification (ICC) and European LeukemiaNet (ELN) classifications. RESULTS: There were 1791 patients aged 18–85 years (median age 42, 1086 males). Normal karyotypes were seen in 646 (36%) patients. The 1145 (64%) abnormal karyotypes comprised 585 (32.7%) with recurrent genetic abnormalities (RGA), 403 (22.5%) with myelodysplasia-related cytogenetic abnormalities (MRC), and 157 (8.8%) with other abnormalities. There were 567 (31.7%) patients with solitary abnormalities and 299 (16.7%) with two abnormalities. Among the 279 (15.6%) patients with ≥ 3 abnormalities, 200 (11.2%) had complex karyotypes (CK) as per the WHO/ICC and 184 (10.3%), as per the ELN definition. There were 158 (8.8%) monosomal karyotypes (MK). Patients with normal karyotypes had a higher median age (45 years) than those with abnormal karyotypes (40 years, p < 0.001), and those with ≥ 3 abnormalities (43 years), than those with fewer abnormalities (39 years, p = 0.005). Patients with CK (WHO/ICC) and monosomal karyotypes had a median age of 48 years. Those with RGA had a lower median age (35 years, p < 0.001) than MRC (46 years) or other abnormalities (44 years). The t(15;17) was the most common abnormality (16.7%),followed by trisomy 8 (11.6%), monosomy 7/del 7q (9.3%), t(8;21) (7.2%), monosomy 5/del 5q (6.7%) and monosomy 17/del 17p (5.2%). CONCLUSION: Our findings confirm the lower age profile of AML in India and show similarities and differences with respect to the frequencies of individual abnormalities compared to the literature. The frequencies of the t(15;17), trisomy 8 and the high-risk abnormalities monosomy 7 and monosomy 5/del 5q were higher, and that of the inv(16), lower than in most reports. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13039-023-00653-1. BioMed Central 2023-09-16 /pmc/articles/PMC10504794/ /pubmed/37716945 http://dx.doi.org/10.1186/s13039-023-00653-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Srivastava, Vivi M. Nair, Sukesh Chandran Sappani, Marimuthu Manipadam, Marie-Therese Kulkarni, Uday P. Devasia, Anup J. Fouzia, N. A. Korula, Anu Lakshmi, Kavitha M. Abraham, Aby Srivastava, Alok Cytogenetic profile of 1791 adult acute myeloid leukemia in India |
title | Cytogenetic profile of 1791 adult acute myeloid leukemia in India |
title_full | Cytogenetic profile of 1791 adult acute myeloid leukemia in India |
title_fullStr | Cytogenetic profile of 1791 adult acute myeloid leukemia in India |
title_full_unstemmed | Cytogenetic profile of 1791 adult acute myeloid leukemia in India |
title_short | Cytogenetic profile of 1791 adult acute myeloid leukemia in India |
title_sort | cytogenetic profile of 1791 adult acute myeloid leukemia in india |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504794/ https://www.ncbi.nlm.nih.gov/pubmed/37716945 http://dx.doi.org/10.1186/s13039-023-00653-1 |
work_keys_str_mv | AT srivastavavivim cytogeneticprofileof1791adultacutemyeloidleukemiainindia AT nairsukeshchandran cytogeneticprofileof1791adultacutemyeloidleukemiainindia AT sappanimarimuthu cytogeneticprofileof1791adultacutemyeloidleukemiainindia AT manipadammarietherese cytogeneticprofileof1791adultacutemyeloidleukemiainindia AT kulkarniudayp cytogeneticprofileof1791adultacutemyeloidleukemiainindia AT devasiaanupj cytogeneticprofileof1791adultacutemyeloidleukemiainindia AT fouziana cytogeneticprofileof1791adultacutemyeloidleukemiainindia AT korulaanu cytogeneticprofileof1791adultacutemyeloidleukemiainindia AT lakshmikavitham cytogeneticprofileof1791adultacutemyeloidleukemiainindia AT abrahamaby cytogeneticprofileof1791adultacutemyeloidleukemiainindia AT srivastavaalok cytogeneticprofileof1791adultacutemyeloidleukemiainindia |